Atavistik Bio

Actio Biosciences

This biotechnology company develops small molecule medicines to treat rare genetic diseases and common conditions for patients with high unmet medical needs.

Attovia Therapeutics

The company develops biparatopic biologics to treat patients with immune-mediated diseases and cancer through a modular protein design platform.

Alesta Therapeutics

This biotechnology company develops oral small molecule therapies for patients with rare genetic disorders including hypophosphatasia and Charcot-Marie-Tooth disease.

Edgewise

This biopharmaceutical company develops oral small molecule therapies to treat patients with rare skeletal and cardiac muscle diseases.

Scenic Biotech

This company develops disease-modifying small molecule therapeutics for patients with rare genetic and neurodegenerative disorders using its proprietary genetic modifier discovery platform.

KyDo Therapeutics

This company develops covalent-allosteric small molecule inhibitors for the treatment of challenging cancer variants within the oncology sector.

HotSpot Therapeutics

The company develops allosteric small molecule medicines for patients with cancer and autoimmune diseases by targeting natural regulatory pockets on proteins.

Athernal Bio

The company develops targeted immunotherapies for patients with high-risk clonal haematopoiesis to prevent the development of blood cancers.